Dates

Friday May 29, 2020, 00:00 - 00:00
Tuesday June 02, 2020, 00:00 - 00:00

ASCO will deliver the latest cancer science to the global community in this year’s ASCO20 Virtual Scientific Program.  The program will feature over 250 oral abstract presentations and 2,500 poster presentations in 24 disease-based and specialty tracks.

Forbius, a clinical-stage protein engineering company that develops biotherapeutics to treat fibrosis and cancer, will report complete safety and biomarker data from its Phase 1 oncology trial with AVID200 in a virtual poster presentation at the ASCO Annual Meeting 2020 .